PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Fruit and leaf extracts significantly lowered blood glucose and glycated hemoglobin while increasing plasma insulin and HDL-cholesterol in diabetic rat models [PMID:28911678, PMID:10967456, PMID:27916421].
Extracts increased serum nitric oxide concentration and vascular dilatation in ethanol-induced hypertensive rats [PMID:34316483].
Fruit extract decreased mucosal injury and regulated inflammatory mediators in wistar rats [PMID:28531922].
Ethanolic leaf extract and specific compounds (squalene, phytol) induced thermogenic adipocyte differentiation in vitro [PMID:31488120, PMID:39698098].
Extracts demonstrated antimicrobial activity against E. coli, S. aureus, B. subtilis, and K. pneumoniae [PMID:34422535, PMID:36284968].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 28216948 (2016) — Averrhoa bilimbi Linn.: A review of its ethnomedicinal uses, phytochemistry, and pharmacology. · Journal of pharmacy & bioallied sciences
- 2.PMID: 39594460 (2024) — Potential Antioxidant Compounds from the Spores of Dicranopteris linearis and the Branches of Averrhoa bilimbi. · Antioxidants (Basel, Switzerland)
- 3.PMID: 28911678 (2017) — Averrhoa bilimbi fruits attenuate hyperglycemia-mediated oxidative stress in streptozotocin-induced diabetic rats. · Journal of food and drug analysis
- 4.PMID: 31488120 (2019) — Novel discovery of Averrhoa bilimbi ethanolic leaf extract in the stimulation of brown fat differentiation program in combating diet-induced obesity. · BMC complementary and alternative medicine
- 5.PMID: 33087977